← All publications

18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors

Giddabasappa A, Jiang ZK, Yang B, … Dann SG · Mol Cancer Ther 2025 · Mol Cancer Ther 24(7):1111-1122

CDK2, CDK4/6, CDK7, CDK9 Ser/Thr kinase Inhibitor discovery & SAR PhosphoSens

Read the paper View on PubMed

More publications on CDK2

Molecular modulators of cyclin-dependent kinase 4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening

Surender S, Haeusser LA, Kuhlburger L, … Tabatabai G · Neuro Oncol 2026

Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors

Davison JR, Hadjithomas M, Romeril SP, … Verdine GL · J Med Chem 2024

AssayQuant Technologies logo

 

 

260 Cedar Hill Street
Marlboro MA 01752

Phone: +1 (508) 804-3155

      

© 2026 AssayQuant Technologies, Inc. - All Rights Reserved - Privacy Policy - Terms & Conditions - FCOI